BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15686946)

  • 1. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
    Fitch RW; Kaneko Y; Klaperski P; Daly JW; Seitz G; Gündisch D
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1221-4. PubMed ID: 15686946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
    Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
    Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
    Carbonnelle E; Sparatore F; Canu-Boido C; Salvagno C; Baldani-Guerra B; Terstappen G; Zwart R; Vijverberg H; Clementi F; Gotti C
    Eur J Pharmacol; 2003 Jun; 471(2):85-96. PubMed ID: 12818695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtypes of neuronal nicotinic acetylcholine receptors involved in nicotine-induced phosphorylation of extracellular signal-regulated protein kinase in PC12h cells.
    Nakayama H; Shimoke K; Isosaki M; Satoh H; Yoshizumi M; Ikeuchi T
    Neurosci Lett; 2006 Jan; 392(1-2):101-4. PubMed ID: 16219421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.
    Imming P; Klaperski P; Stubbs MT; Seitz G; Gündisch D
    Eur J Med Chem; 2001 Apr; 36(4):375-88. PubMed ID: 11461763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
    Pérez EG; Méndez-Gálvez C; Cassels BK
    Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potencies and channel properties induced by semirigid agonists at frog nicotinic acetylcholine receptors.
    Spivak CE; Waters J; Witkop B; Albuquerque EX
    Mol Pharmacol; 1983 Mar; 23(2):337-43. PubMed ID: 6300643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes.
    Slater YE; Houlihan LM; Maskell PD; Exley R; Bermúdez I; Lukas RJ; Valdivia AC; Cassels BK
    Neuropharmacology; 2003 Mar; 44(4):503-15. PubMed ID: 12646287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
    Chellappan SK; Xiao Y; Tueckmantel W; Kellar KJ; Kozikowski AP
    J Med Chem; 2006 May; 49(9):2673-6. PubMed ID: 16640326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-Azaindole derivatives as potential partial nicotinic agonists.
    Stoit AR; den Hartog AP; Mons H; van Schaik S; Barkhuijsen N; Stroomer C; Coolen HK; Reinders JH; Adolfs TJ; van der Neut M; Keizer H; Kruse CG
    Bioorg Med Chem Lett; 2008 Jan; 18(1):188-93. PubMed ID: 18006307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of 3-iodocytisine: pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites.
    Zambrano CA; Marks MJ; Cassels BK; Maccioni RB
    Neuropharmacology; 2009 Sep; 57(3):332-42. PubMed ID: 19481555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
    Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
    Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
    Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor partial agonists alter catecholamine homeostasis and response to nicotine in PC12 cells.
    Turcanu DS; Kirtok N; Eibl C; Guendisch D; LaGamma EF; Nankova BB
    Neurosci Lett; 2012 May; 516(2):212-6. PubMed ID: 22503726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord.
    Khan IM; Wennerholm M; Singletary E; Polston K; Zhang L; Deerinck T; Yaksh TL; Taylor P
    J Neurocytol; 2004 Sep; 33(5):543-56. PubMed ID: 15906161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
    Yohannes D; Procko K; Lebel LA; Fox CB; O'Neill BT
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2316-9. PubMed ID: 18356044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the nitrogen substitution in three cytisine derivatives as ligands for the neuronal nAChRs: a structural and theoretical study.
    Bombieri G; Meneghetti F; Artali R; Tasso B; Canu Boido C; Sparatore F
    Chem Biodivers; 2008 Sep; 5(9):1867-78. PubMed ID: 18816516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.